NMRA · Neumora Therapeutics, Inc. · Proposed Sales
$0.33
-0.01 (-3.78%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q4 2025 earnings call transcript
Going-concern doubt
— flagged Nov 16, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, the Company has concluded that substantial doubt exists about its ability to continue as a going concern.”View the 10-Q filed Nov 16, 2026
Market Cap
$63.01M
Shares
188.69M
Volume · Nov 20
1.06M
Avg daily vol (3M)
1.67M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-08-21 | Aurora Daljit Singh | Officer | 41,608 | 2026-08-21 | Merrill Lynch |
| 2026-08-20 | Aurora Daljit Singh | Officer | 134,452 | 2026-08-20 | Merrill Lynch |
| 2026-08-19 | Aurora Daljit Singh | Officer | 61,918 | 2026-08-19 | Merrill Lynch |
| 2026-08-18 | Aurora Daljit Singh | Officer | 69,149 | 2026-08-18 | Merrill Lynch |
| 2026-08-17 | Aurora Daljit Singh | Officer | 146,706 | 2026-08-17 | Merrill Lynch |
| 2026-02-17 | Milligan Michael Lee | Officer | 1,436 | 2026-02-17 | Merrill Lynch |
| 2026-02-17 | BERNS PAUL L | Officer | 9,819 | 2026-02-17 | Merrill Lynch |
| 2026-02-17 | Pinto Joshua | Officer | 5,967 | 2026-02-17 | Merrill Lynch |
| 2026-02-17 | Aurora Daljit Singh | Officer | 6,165 | 2026-02-17 | Merrill Lynch |
| 2025-11-12 | Aurora Family Trust | Director, Officer | 114,703 | 2025-11-11 | Merrill Lynch |
| 2025-03-12 | Henry Gosebruch | Officer, Director | 15,000 | 2025-03-12 | J.P. Morgan Securities LLC |
| 2025-02-18 | Pinto Joshua | Officer | 8,048 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Gosebruch Henry O | Officer, Director | 6,857 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Aurora Daljit Singh | Officer | 8,565 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Suh Carol Y. | Officer | 9,540 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | BERNS PAUL L | Officer | 13,871 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Lenz Robert A. | Officer | 5,614 | 2025-02-18 | Merrill Lynch |
| 2025-02-18 | Milligan Michael Lee | Officer | 1,978 | 2025-02-18 | Merrill Lynch |
| 2024-10-18 | Fust Matthew K | Director | 14,049 | 2024-10-18 | Merrill Lynch |
| 2024-10-17 | Fust Matthew K | Director | 7,739 | 2024-10-17 | Merrill Lynch |
| 2024-10-10 | Lenz Robert A. | Officer | 8,260 | 2024-10-10 | Merrill Lynch |
| 2024-10-09 | Lenz Robert A. | Officer | 5,563 | 2024-10-09 | Merrill Lynch |
| 2024-09-18 | Lenz Robert A. | Officer | 10,676 | 2024-09-18 | Merrill Lynch |
| 2024-09-17 | Lenz Robert A. | Officer | 30,788 | 2024-09-17 | Merrill Lynch |
| 2024-09-12 | Lenz Robert A. | Officer | 32,948 | 2024-09-12 | Merrill Lynch |
| 2024-08-22 | Pinto Joshua | Officer | 100,000 | 2024-08-22 | Merrill Lynch |
Showing 1–26 of 26 filings
Key facts
CIK
1885522
CUSIP
640979100
13F (30d)
143 filings
117 filers
Visit website
Investor relations